Stay updated on BI 1323495 Dose Tolerance & Inflammation Biomarkers Clinical Trial
Sign up to get notified when there's something new on the BI 1323495 Dose Tolerance & Inflammation Biomarkers Clinical Trial page.

Latest updates to the BI 1323495 Dose Tolerance & Inflammation Biomarkers Clinical Trial page
- Check3 days agoChange DetectedThe page now displays the ClinicalTrials.gov record for the BI 1323495 bronchiectasis study, including its study design, participant criteria, results measures, and record history.SummaryDifference45%

- Check10 days agoChange DetectedThe footer now shows revision v3.8.0 instead of v3.7.2. The study page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check17 days agoChange DetectedA general NIH notice announces a transition from the term “Artificial Intelligence” to “Super Intelligence” across federal agency content. The prior 403 error message is no longer shown.SummaryDifference2%

- Check24 days agoChange DetectedThe footer’s site revision label advances from v3.7.1 to v3.7.2, while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check31 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check52 days agoChange DetectedA 403 Forbidden error page is displayed, blocking access to the study record content while the site header and footer remain visible.SummaryDifference18%

Stay in the know with updates to BI 1323495 Dose Tolerance & Inflammation Biomarkers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BI 1323495 Dose Tolerance & Inflammation Biomarkers Clinical Trial page.